z-logo
open-access-imgOpen Access
Targeting MYCN and ALK in resistant and relapsing neuroblastoma
Author(s) -
Elizabeth R. Tucker,
Evon Poon,
Louis Chesler
Publication year - 2019
Publication title -
cancer drug resistance
Language(s) - English
Resource type - Journals
ISSN - 2578-532X
DOI - 10.20517/cdr.2019.009
Subject(s) - neuroblastoma , anaplastic lymphoma kinase , cancer research , crizotinib , medicine , targeted therapy , oncogene , alk inhibitor , disease , oncology , biology , cancer , lung cancer , genetics , cell cycle , cell culture , malignant pleural effusion

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom